Learn More
Cayman Chemical GGACKhydrochlorIde 5mg

Supplier: Cayman Chemical 346185 MG

A PDE5 inhibitor increases lung cGMP levels attenuates the development of compensatory right ventricular hypertrophy and reduces pulmonary arterial wall thickening in a rat model of monocrotaline-induced pulmonary hypertension at 1 and 5 mg/kg increases creatine clearance and decreases BUN and serum MDA levels in a rat model of renal ischemia-reperfusion injury induces penile erections in conscious rabbits and in rabbits with acute spinal cord injury at 0.3 and 10 mg/kg
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.